ENANTA PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, December 30, 1999, a trademark application was filed for ENANTA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the ENANTA PHARMACEUTICALS trademark a serial number of 75883929. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 23, 2014. This trademark is owned by Enanta Pharmaceuticals, Inc.. The ENANTA PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development services in the field of identification of compounds as potential therapeutic products
enanta pharmaceuticals

General Information

Serial Number75883929
Word MarkENANTA PHARMACEUTICALS
Filing DateThursday, December 30, 1999
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 23, 2014
Registration Number2776014
Registration DateTuesday, October 21, 2003
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 20, 2001

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICALS, INC."
Goods and Servicesresearch and development services in the field of identification of compounds as potential therapeutic products
Lining/Stippling StatementThe stippling shown in the mark is for shading purposes only.
Pseudo MarkE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 23, 2014
Primary Code042
First Use Anywhere DateWednesday, September 4, 2002
First Use In Commerce DateWednesday, September 4, 2002

Trademark Owner History

Party NameEnanta Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameEnanta Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameEnanta Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, May 23, 2014CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Friday, October 2, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 11, 2009REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Friday, September 11, 2009PAPER RECEIVED
Friday, August 14, 2009POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, August 12, 2009ASSIGNED TO PARALEGAL
Tuesday, August 11, 2009TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 11, 2009TEAS SECTION 7 REQUEST RECEIVED
Tuesday, October 21, 2003REGISTERED-PRINCIPAL REGISTER
Friday, August 22, 2003ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 20, 2003CASE FILE IN TICRS
Friday, June 20, 2003CASE FILE IN TICRS
Friday, June 13, 2003STATEMENT OF USE PROCESSING COMPLETE
Friday, June 13, 2003EXTENSION 4 GRANTED
Thursday, May 8, 2003EXTENSION 4 FILED
Thursday, May 8, 2003USE AMENDMENT FILED
Thursday, May 8, 2003PAPER RECEIVED
Thursday, January 30, 2003EXTENSION 3 GRANTED
Wednesday, November 13, 2002EXTENSION 3 FILED
Wednesday, November 13, 2002PAPER RECEIVED
Monday, June 24, 2002PAPER RECEIVED
Sunday, May 12, 2002EXTENSION 2 GRANTED
Thursday, April 25, 2002EXTENSION 2 FILED
Thursday, April 25, 2002PAPER RECEIVED
Friday, November 30, 2001EXTENSION 1 GRANTED
Wednesday, November 14, 2001EXTENSION 1 FILED
Tuesday, May 15, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 20, 2001PUBLISHED FOR OPPOSITION
Friday, January 19, 2001NOTICE OF PUBLICATION
Wednesday, November 15, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 14, 2000EXAMINER'S AMENDMENT MAILED
Monday, June 12, 2000NON-FINAL ACTION MAILED
Friday, June 2, 2000ASSIGNED TO EXAMINER

Related Keywords

pharmaceuticals enanta potential therapeutic products compounds identification development services field research